Multiple preconditioning paradigms converge on interferon regulatory factor-dependent signaling to promote tolerance to ischemic brain injury

Journal of Neuroscience

Volumn 31, Issue 23, 2011, Pages 8456-8463

  Stevens, Susan L ^a   Leung, Philberta Y ^a   Vartanian, Keri B ^a   Gopalan, Banu ^a   Yang, Tao ^b   Simon, Roger P ^a   Stenzel Poore, Mary P ^c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; INTERFERON REGULATORY FACTOR; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE SEQUENCE; ISCHEMIC PRECONDITIONING; MALE; MOLECULAR MECHANICS; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STIMULUS RESPONSE;

ANIMALS; BRAIN; BRAIN ISCHEMIA; GENE EXPRESSION; INTERFERON REGULATORY FACTORS; ISCHEMIC PRECONDITIONING; LIPOPOLYSACCHARIDES; MALE; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 79958248587     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0821-11.2011     Document Type: Article

References (43)

1. Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4:499-511.
2. Au WC, Yeow WS, Pitha PM (2001) Analysis of functional domains of in-terferon regulatory factor 7 and its association with IRF-3. Virology 280:273-282.
3. Biswas SK, Bist P, Dhillon MK, Kajiji T, Del Fresno C, Yamamoto M, Lopez-Collazo E, Akira S, Tergaonkar V (2007) Role for MyD88-independent, TRIF pathway in lipid A/TLR4-induced endotoxin tolerance. J Immunol 179:4083-4092.
4. Brea D, Blanco M, Ramos-Cabrer P, Moldes O, Arias S, Perez-Mato M, Leira R, Sobrino T, Castillo J (2011) Toll-like receptors 2 and 4 in ischemic stroke: outcome and therapeutic values. J Cereb Blood Flow Metab. Advance online publication. Retrieved Feb. 2011. doi:10.1038/ jcbfm.2010.231.
5. Broad A, Kirby JA, Jones DE (2007) Toll-like receptor interactions: tolerance of MyD88-dependent cytokines but enhancement of MyD88-independent interferon-beta production. Immunology 120:103-111.
6. Buss C, Opitz B, Hocke AC, Lippmann J, van Laak V, Hippenstiel S, Krüll M, Suttorp N, Eitel J (2010) Essential role of mitochondrial antiviral signaling, IFN regulatory factor (IRF)3, and IRF7 in Chlamydophila pneumoniae-mediated IFN-beta response and control of bacterial replication in human endothelial cells. J Immunol 184:3072-3078.
7. Cao CX, Yang QW, Lv FL, Cui J, Fu HB, Wang JZ (2007) Reduced cerebral ischemia-reperfusion injury in Toll-like receptor 4 deficient mice. Biochem Biophys Res Commun 353:509-514.
8. da Silva R, Lucchinetti E, Pasch T, Schaub MC, Zaugg M (2004) Ischemic but not pharmacological preconditioning elicits a gene expression profile similar to unprotected myocardium. Physiol Genomics 20:117-130.
9. Dirnagl U, Becker K, Meisel A (2009) Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol 8:398-412.
10. Hickey EJ, You X, Kaimaktchiev V, Stenzel-Poore M, Ungerleider RM (2007) Lipopolysaccharide preconditioning induces robust protection against brain injury resulting from deep hypothermic circulatory arrest. J Thorac Cardiovasc Surg 133:1588-1596.
11. Hochberg Y, Benjamini Y (1990) More powerful procedures for multiple significance testing. Stat Med 9:811-818.
12. Honda K, Yanai H, Mizutani T, Negishi H, Shimada N, Suzuki N, Ohba Y, Takaoka A, Yeh WC, Taniguchi T (2004) Role of a transductional-tran-scriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc Natl Acad Sci U S A 101:15416-15421.
13. Hua F, Ma J, Ha T, Kelley J, Williams DL, Kao RL, Kalbfleisch JH, Browder IW, Li C (2008) Preconditioning with a TLR2 specific ligand increases resistance to cerebral ischemia/reperfusion injury. J Neuroimmunol 199:75-82.
14. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249-264.
15. Kanehisa M, Goto S (2000) KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28:27-30.
16. Kanehisa M, Goto S, Hattori M, Aoki-Kinoshita KF, Itoh M, Kawashima S, Katayama T, Araki M, Hirakawa M (2006) From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res 34:D354-D357.
17. Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M (2010) KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 38:D355-D360.
18. Karikó K, Weissman D, Welsh FA (2004) Inhibition of Toll-like receptor and cytokine signaling-a unifying theme in ischemic tolerance. J Cereb Blood Flow Metab 24:1288-1304.
19. Kraus J, Voigt K, Schuller AM, Scholz M, Kim KS, Schilling M, Schäbitz WR, Oschmann P, Engelhardt B (2008) Interferon-beta stabilizes barrier characteristics of the blood- brain barrier in four different species in vitro. Mult Scler 14:843-852.
20. Lehnardt S, Lehmann S, Kaul D, Tschimmel K, Hoffmann O, Cho S, Krueger C, Nitsch R, Meisel A, Weber JR (2007) Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia. J Neuroimmunol 190:28-33.
21. Liu H, Xin L, Chan BP, Teoh R, Tang BL, Tan YH (2002) Interferon beta administration confers a beneficial outcome in a rabbit model of throm-boembolic cerebral ischemia. Neurosci Lett 327:146-148.
22. Marsh B, Stevens SL, Packard AE, Gopalan B, Hunter B, Leung PY, Harrington CA, Stenzel-Poore MP (2009a) Systemic lipopolysaccharide protects the brain from ischemic injury by reprogramming the response of the brain to stroke: a critical role for IRF3. J Neurosci 29:9839-9849.
23. Marsh BJ, Stevens SL, Hunter B, Stenzel-Poore MP (2009b) Inflammation and the emerging role of the Toll-like receptor system in acute brain ischemia. Stroke 40:S34-S37.
24. Minagar A, Long A, Ma T, Jackson TH, Kelley RE, Ostanin DV, Sasaki M, Warren AC, Jawahar A, Cappell B, Alexander JS (2003) Interferon (IFN)-beta1aand IFN-beta 1bblock IFN-gamma-induced disintegration of endothelial junction integrity and barrier. Endothelium 10:299-307.
25. Ning S, Huye LE, Pagano JS (2005) Regulationof the transcriptional activity of the IRF7 promoter by a pathway independent of interferon signaling. J Biol Chem 280:12262-12270.
26. Pradillo JM, Fernández-López D, García-Yébenes I, Sobrado M, Hurtado O, Moro MA, Lizasoain I (2009) Toll-like receptor 4 is involved in neuro-protection afforded by ischemic preconditioning. J Neurochem 109: 287-294.
27. Ridder DA, Schwaninger M (2009) NF-kappaB signaling in cerebral ischemia. Neuroscience 158:995-1006.
28. Rosenzweig HL, Lessov NS, Henshall DC, Minami M, Simon RP, Stenzel-Poore MP (2004) Endotoxin preconditioning prevents the cellular inflammatory response during ischemic neuroprotection in mice. Stroke 35:2576-2581.
29. Rosenzweig HL, Minami M, Lessov NS, Coste SC, Stevens SL, Henshall DC, Meller R, Simon RP, Stenzel-Poore MP (2007) Endotoxin preconditioning protects against the cytotoxic effects of TNFa after stroke: a novel role for TNFa in LPS-ischemic tolerance. J Cereb Blood Flow Metab 27:1663-1674.
30. Sato M, Tanaka N, Hata N, Oda E, Taniguchi T (1998) Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFN-beta gene. FEBS Lett 425:112-116.
31. Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, Nakao K, Nakaya T, Katsuki M, Noguchi S, Tanaka N, Taniguchi T (2000) Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13:539-548.
32. Sergeev P, da Silva R, Lucchinetti E, Zaugg K, Pasch T, Schaub MC, Zaugg M (2004) Trigger-dependent gene expression profiles in cardiac preconditioning: evidence for distinct genetic programs in ischemic and anesthetic preconditioning. Anesthesiology 100:474-488.
33. Stenzel-Poore MP, Stevens SL, Xiong Z, Lessov NS, Harrington CA, Mori M, Meller R, Rosenzweig HL, Tobar E, Shaw TE, Chu X, Simon RP (2003) Effect of ischemic preconditioning on genomic response to cerebral ischemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet 362:1028-1037.
34. Stenzel-Poore MP, Stevens SL, King JS, Simon RP (2007) Preconditioning reprograms the response to ischemic injury and primes the emergence of unique endogenous neuroprotective phenotypes: a speculative synthesis. Stroke 38:680-685.
35. Stevens SL, Bao J, Hollis J, Lessov NS, Clark WM, Stenzel-Poore MP (2002) The use of flow cytometry to evaluate temporal changes in inflammation. Brain Res 932:110-119.
36. Stevens SL, Ciesielski TM, Marsh BJ, Yang T, Homen DS, Boule JL, Lessov NS, Simon RP, Stenzel-Poore MP (2008) Toll-like receptor9: anew target of ischemic preconditioning in the brain. J Cereb Blood Flow Metab 28:1040-1047.
37. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR (1990) A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 10:290-293.
38. Tang SC, Arumugam TV, Xu X, Cheng A, Mughal MR, Jo DG, Lathia JD, Siler DA, Chigurupati S, Ouyang X, Magnus T, Camandola S, Mattson MP (2007) Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc Natl Acad Sci USA 104: 13798-13803.
39. Tasaki K, Ruetzler CA, Ohtsuki T, Martin D, Nawashiro H, Hallenbeck JM (1997) Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats. Brain Res 748:267-270.
40. Vadigepalli R, Chakravarthula P, Zak DE, Schwaber JS, Gonye GE (2003) PAINT: a promoter analysis and interaction network generation tool for gene regulatory network identification. Omics 7:235-252.
41. Veldhuis WB, Derksen JW, Floris S, Van Der Meide PH, De Vries HE, Schep-ers J, Vos IM, Dijkstra CD, Kappelle LJ, Nicolay K, Bär PR (2003a) Interferon-beta blocks infiltration of inflammatory cells and reduces in-farct volume after ischemic stroke in the rat. J Cereb Blood Flow Metab 23:1029-1039.
42. Veldhuis WB, Floris S, van der Meide PH, Vos IM, de Vries HE, Dijkstra CD, Bär PR, Nicolay K (2003b) Interferon-beta prevents cytokine-induced neutrophil infiltration and attenuates blood-brain barrier disruption. J Cereb Blood Flow Metab 23:1060-1069.
43. Yang H, Ma G, Lin CH, Orr M, Wathelet MG (2004) Mechanism for tran-scriptional synergy between interferon regulatory factor (IRF)-3 and IRF-7 in activation of the interferon-beta gene promoter. Eur J Biochem 271:3693-3703.